These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience.
    Author: Buzdar AU, Singletary SE, Booser DJ, Frye DK, Wasaff B, Hortobagyi GN.
    Journal: Surg Oncol Clin N Am; 1995 Oct; 4(4):715-34. PubMed ID: 8535907.
    Abstract:
    Seven hundred fifty-two patients with stage III disease (of those, 178 patients with inflammatory carcinoma) were treated with a combined modality approach at our institute in seven prospective studies. After three to four cycles of chemotherapy, each patient was treated with local therapy. An estimated 54% of patients with stage IIIA disease and 24% of patients with stage IIIB disease were free of disease. An estimated 30% of patients with inflammatory carcinoma of breast were free of disease beyond 10 years with this approach.
    [Abstract] [Full Text] [Related] [New Search]